Reply to: "Comment on 'Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'"

Alexander Egeberg, Lars Erik Bryld, Lone Skov

1 Citation (Scopus)
Original languageEnglish
JournalJournal of the American Academy of Dermatology
Volume85
Issue number6
Pages (from-to)e379
ISSN0190-9622
DOIs
Publication statusPublished - Dec 2021

Keywords

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Pharmaceutical Preparations
  • Psoriasis/drug therapy

Cite this